vs
Side-by-side financial comparison of COASTAL FINANCIAL CORP (CCB) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
COASTAL FINANCIAL CORP is the larger business by last-quarter revenue ($138.0M vs $75.5M, roughly 1.8× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -5.8%). COASTAL FINANCIAL CORP produced more free cash flow last quarter ($246.1M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -3.6%).
Fidelity National Financial, Inc., is an American provider of title insurance and settlement services to the real estate and mortgage industries. A Fortune 500 company, Fidelity National Financial generated approximately $8.469 billion in annual revenue in 2019 from its title and real estate-related operations. The company was the first instance of an attorney licensed by a Native American Tribe being certified as "authorized house counsel" in the state of Florida.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
CCB vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $138.0M | $75.5M |
| Net Profit | — | — |
| Gross Margin | — | 69.3% |
| Operating Margin | 12.4% | 22.7% |
| Net Margin | — | — |
| Revenue YoY | -5.8% | 27.7% |
| Net Profit YoY | — | — |
| EPS (diluted) | $0.84 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $138.0M | $75.5M | ||
| Q3 25 | $144.7M | $54.5M | ||
| Q2 25 | $119.4M | $52.4M | ||
| Q1 25 | $139.5M | $46.0M | ||
| Q4 24 | $146.5M | $59.1M | ||
| Q3 24 | $151.1M | $80.5M | ||
| Q2 24 | $135.3M | $47.1M | ||
| Q1 24 | $148.4M | $43.8M |
| Q4 25 | — | — | ||
| Q3 25 | $13.6M | $8.8M | ||
| Q2 25 | $11.0M | $5.9M | ||
| Q1 25 | $9.7M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $13.5M | $20.3M | ||
| Q2 24 | $11.6M | $-4.5M | ||
| Q1 24 | $6.8M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | 12.4% | 22.7% | ||
| Q3 25 | 12.4% | 17.6% | ||
| Q2 25 | 12.0% | 12.7% | ||
| Q1 25 | 8.4% | 8.7% | ||
| Q4 24 | 11.7% | 22.6% | ||
| Q3 24 | 10.8% | 27.4% | ||
| Q2 24 | 11.1% | -4.6% | ||
| Q1 24 | 5.9% | -5.3% |
| Q4 25 | — | — | ||
| Q3 25 | 9.4% | 16.2% | ||
| Q2 25 | 9.2% | 11.2% | ||
| Q1 25 | 7.0% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 8.9% | 25.2% | ||
| Q2 24 | 8.6% | -9.6% | ||
| Q1 24 | 4.6% | -11.0% |
| Q4 25 | $0.84 | $0.26 | ||
| Q3 25 | $0.88 | $0.17 | ||
| Q2 25 | $0.71 | $0.12 | ||
| Q1 25 | $0.63 | $0.06 | ||
| Q4 24 | $0.95 | $0.40 | ||
| Q3 24 | $0.97 | $0.41 | ||
| Q2 24 | $0.84 | $-0.09 | ||
| Q1 24 | $0.50 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $491.0M | $130.3M |
| Total Assets | $4.7B | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $491.0M | $130.3M | ||
| Q3 25 | $475.3M | $115.3M | ||
| Q2 25 | $461.7M | $104.7M | ||
| Q1 25 | $449.9M | $97.1M | ||
| Q4 24 | $438.7M | $92.1M | ||
| Q3 24 | $331.9M | $71.1M | ||
| Q2 24 | $316.7M | $48.5M | ||
| Q1 24 | $303.7M | $51.0M |
| Q4 25 | $4.7B | $216.3M | ||
| Q3 25 | $4.6B | $202.9M | ||
| Q2 25 | $4.5B | $194.9M | ||
| Q1 25 | $4.3B | $196.2M | ||
| Q4 24 | $4.1B | $213.3M | ||
| Q3 24 | $4.1B | $220.7M | ||
| Q2 24 | $4.0B | $205.0M | ||
| Q1 24 | $3.9B | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $254.6M | $14.4M |
| Free Cash FlowOCF − Capex | $246.1M | $14.4M |
| FCF MarginFCF / Revenue | 178.3% | 19.1% |
| Capex IntensityCapex / Revenue | 6.1% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $436.4M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $254.6M | $14.4M | ||
| Q3 25 | $59.0M | $9.7M | ||
| Q2 25 | $66.0M | $14.1M | ||
| Q1 25 | $71.7M | $3.6M | ||
| Q4 24 | $259.8M | $15.6M | ||
| Q3 24 | $62.6M | $11.0M | ||
| Q2 24 | $72.1M | $1.0M | ||
| Q1 24 | $56.8M | $11.2M |
| Q4 25 | $246.1M | $14.4M | ||
| Q3 25 | $57.4M | $9.7M | ||
| Q2 25 | $64.0M | $14.1M | ||
| Q1 25 | $68.9M | $3.6M | ||
| Q4 24 | $249.9M | $15.6M | ||
| Q3 24 | $60.2M | $11.0M | ||
| Q2 24 | $69.5M | $1.0M | ||
| Q1 24 | $55.0M | — |
| Q4 25 | 178.3% | 19.1% | ||
| Q3 25 | 39.7% | 17.7% | ||
| Q2 25 | 53.6% | 26.8% | ||
| Q1 25 | 49.4% | 7.7% | ||
| Q4 24 | 170.6% | 26.4% | ||
| Q3 24 | 39.8% | 13.7% | ||
| Q2 24 | 51.3% | 2.1% | ||
| Q1 24 | 37.1% | — |
| Q4 25 | 6.1% | 0.0% | ||
| Q3 25 | 1.2% | 0.0% | ||
| Q2 25 | 1.7% | 0.0% | ||
| Q1 25 | 2.0% | 0.1% | ||
| Q4 24 | 6.8% | 0.0% | ||
| Q3 24 | 1.6% | 0.0% | ||
| Q2 24 | 1.9% | 0.0% | ||
| Q1 24 | 1.2% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | 4.34× | 1.10× | ||
| Q2 25 | 5.99× | 2.41× | ||
| Q1 25 | 7.37× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.65× | 0.54× | ||
| Q2 24 | 6.22× | — | ||
| Q1 24 | 8.35× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCB
| Other | $74.7M | 54% |
| Baa S Credit Enhancements | $47.3M | 34% |
| Baa S Program Income | $8.4M | 6% |
| Transaction Fees | $4.9M | 4% |
| Servicing And Other Baa S Fees | $1.6M | 1% |
| Baa S Fraud Enhancements | $1.1M | 1% |
PBYI
Segment breakdown not available.
